That is a very pleasant surprise.
So begins a very exciting 6 months or so for shareholders. I've been involved in a few that had an extended wait then big decision day (knocked back). But this seems much more iterative and pointed towards a positive review.
Expect a few bumps along the way with questons/requests for info from the FDA which hopefully the company can satisfy.
Strapping myself in.
Ann: EBR submits final PMA module to the U.S. FDA, page-2
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.050(4.50%) |
Mkt cap ! $357.4M | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.24 | $1.10 | $898.7K | 749.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1427 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 12000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |